Key Figures1

kEUR

H1 2023

H1 2022

Change

 

 

 

 

Revenue

131,834

133,656

-1.4%

Custom Projects

59,537

72,613

-18.0%

Contract Manufacturing

56,693

48,398

17.1%

Generics & Cosmetics

15,604

12,645

23.4%

EBITDA

-19,387

26,706

-172.6%

EBITDA in % of revenue

-14.7%

20.0%

-34.7 ppts

Operating result (EBIT)

-34,464

15,482

-322.6%

Operating result (EBIT) in % of revenue

-26.1%

11.6%

-37.7 ppts

Result for the period

-34,266

10,247

-434.4%

Result for the period in % of revenue

-26.0%

7.7%

-33.7 ppts

Earnings per share (EUR), basic

-1.04

0.31

-435.7%

Return on net operating assets (RONOA)

-8.8%

14.3%

-23.0 ppts

Cash and cash equivalents (end of period)

8,985

66,436

-86.5%

Net cash flow from operating activities

-48,322

-7,659

530.9%

Capital expenditures

19,346

37,926

-49.0%

Capital expenditures in % of revenue

14.7%

28.4%

-13.7 ppts

Total assets (end of period)

589,123

579,253

1.7%

Equity ratio (end of period)

65.2%

73.8%

-8.5 ppts

Employees (# of FTEs, average)

1,181

1,156

2.1%

1 This table and report include references to operational indicators and alternative financial performance measures (APM) that are not defined or specified by IFRS. These APM should be regarded as complementary information to and not as substitutes of the Group’s consolidated financial results based on IFRS. For the definitions of the main operational indicators and APM used, including related abbreviations, as well as for selected reconciliations to IFRS, please refer to the section “Definitions and reconciliations” of this report.